Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies
about
Increased cystatin C expression in the pre-eclamptic placentaSex- and diet-specific changes of imprinted gene expression and DNA methylation in mouse placenta under a high-fat dietStress-related programming of autonomic imbalance: role in allergy and asthma.Fetal effects of psychoactive drugsChildren of addicted womenThe effect of antenatal depression and selective serotonin reuptake inhibitor treatment on nerve growth factor signaling in human placenta.Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: implications for fetal programmingMethamphetamines and pregnancy outcomesLow-affinity uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (4-Di-1-ASP) in BeWo cellsAltered expression of norepinephrine transporter and norepinephrine in human placenta cause pre-eclampsia through regulated trophoblast invasion.The emerging importance of transporter proteins in the psychopharmacological treatment of the pregnant patient.Drug transporters in the human blood-placental barrier.Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues.Maternal Pharmacokinetics and Fetal Disposition of (±)-Citalopram during Mouse Pregnancy.Insights into the complex influence of 5-HT signaling on thalamocortical axonal system development.Pharmacological potential of biogenic amine-polyamine interactions beyond neurotransmission.Behavioral epigenetics and the developmental origins of child mental health disorders.Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions.The importance of drug transporters in human pluripotent stem cells and in early tissue differentiation.Placental control of drug delivery.ADRB1 as a potential target for gene therapy of pregnancy induced hypertension and gestational diabetes mellitus.Serotonin transporter protects the placental cells against apoptosis in caspase 3-independent pathway.Nicotinic acetylcholine receptors (nAChR) are increased in the pre-eclamptic placenta.Identification of placental nutrient transporters associated with intrauterine growth restriction and pre-eclampsia.Effects of low oxygen levels on the expression and function of transporter OCTN2 in BeWo cellsDifferential Regulation of Adhesion and Phagocytosis of Resting and Activated Microglia by Dopamine
P2860
Q28283613-69D5A787-396A-498F-9043-DDC54919A105Q28744059-5A674907-D50B-4E5B-9B3F-891B1A4BFB14Q30444516-C45121DE-3F9C-43E9-BD7D-0538899C9B40Q30479705-EB0EE5E0-732B-4FA6-B2CE-7411556503F5Q34111219-65D49721-FF00-4A31-99F5-FE0F358BA195Q35000963-6CCC54A5-41AC-4621-AE31-1492632AC18EQ35161157-A978B79C-D807-4218-9FEB-E81F253767FBQ35220283-D9679127-9C9A-4BAC-8626-E165B328C743Q35928472-E8BAA36B-C670-4139-A090-DABA6949EB2AQ36778205-74B7ABF3-4443-47AB-84E4-ABC2F1692387Q37024001-44AED8AB-C251-4846-8B95-72EEF0AED69AQ37395889-B3E571A7-AE17-426E-B6F1-DB426199DC84Q37604379-7A4DF1DE-7B03-4B65-B7B0-352D07B26559Q37742091-360CEA84-0E87-428C-98D6-EF576342C44DQ38011199-3D65336A-D5E6-4E53-9D48-1179DE96B1BCQ38076471-A41FB450-1C3C-4A36-9F17-C97F01EE1D86Q38236039-D64A43FC-FE51-404E-909F-6293352AE0A2Q38622785-BD968325-720B-4231-B9ED-28F3808C7408Q38642449-5BAA4C66-6B7E-4062-A68F-F4ACA8BA9133Q38928337-A439AE00-8F4D-4A82-BC01-94FBC64C2FD6Q45872238-1943EEBB-23A4-44D0-855C-42B345F5453EQ48327416-D2CEE7E1-BF92-4DD8-B77D-698160A67A3DQ53602844-C56043CD-654D-4335-9678-530FB02E008EQ55026635-99AA45E6-ABE6-4C69-94B2-DDA728B1B337Q57104820-5A65495B-56D4-46BD-BBD7-D3FB971FE271Q58750811-CD553BA5-5476-47EE-91D8-D72316C6AE1E
P2860
Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Norepinephrine transporter (NE ...... c and normotensive pregnancies
@ast
Norepinephrine transporter (NE ...... c and normotensive pregnancies
@en
Norepinephrine transporter (NE ...... c and normotensive pregnancies
@nl
type
label
Norepinephrine transporter (NE ...... c and normotensive pregnancies
@ast
Norepinephrine transporter (NE ...... c and normotensive pregnancies
@en
Norepinephrine transporter (NE ...... c and normotensive pregnancies
@nl
prefLabel
Norepinephrine transporter (NE ...... c and normotensive pregnancies
@ast
Norepinephrine transporter (NE ...... c and normotensive pregnancies
@en
Norepinephrine transporter (NE ...... c and normotensive pregnancies
@nl
P2093
P921
P1433
P1476
Norepinephrine transporter (NE ...... c and normotensive pregnancies
@en
P2093
B Bottalico
E Hernandez-Andrade
J Brodszki
S R Hansson
P304
P356
10.1016/J.PLACENTA.2003.10.017
P407
P577
2004-07-01T00:00:00Z